Tutorial
RH CHAIN
…
Wallet
Overview
Follow the Money
Daily Brief
Live
Congress
Corporate Insiders
Government Money
Political Influence
Institutions
Washington Network
Follow the Power
Disclosure Clock
AI Investigator
Watchlist
Convergence
INSIDER Alpha
Signal ledger
Historical Replay
Robinhood Chain
Proof
Trading
Token
Pro
Account
Methodology
Match review
Launch readiness
Tutorial
01
Overview
02
Follow the Money
03
Daily Brief
04
Live
05
Congress
06
Corporate Insiders
07
Government Money
08
Political Influence
09
Institutions
10
Washington Network
11
Follow the Power
12
Disclosure Clock
13
AI Investigator
14
Watchlist
Convergence
INSIDER Alpha
Signal ledger
Historical Replay
Robinhood Chain
Proof
Trading
Token
Pro
Account
Methodology
Match review
Launch readiness
Overview
Follow the Money
Daily Brief
Live
Congress
Corporate Insiders
Government Money
Political Influence
Institutions
Washington Network
Follow the Power
Disclosure Clock
AI Investigator
Watchlist
Convergence
INSIDER Alpha
Signal ledger
Historical Replay
Robinhood Chain
Proof
Trading
Token
Pro
Account
Methodology
Match review
Launch readiness
Tutorial
Data sources
SEC FORM 4
2h ago
HOUSE PTR
2h ago
SEC 13F
2h ago
ROBINHOOD CHAIN
2h ago
Lobbying registrant
CC
CAPITOL COUNSEL LLC
Open in network
○
Watch profile
Disclosed transactions
0
Buys / sells
0 / 0
Max Insider Score
—
Connections
25
with evidence
Disclosed transactions
No records
No transactions recorded for this profile.
Verified connections
Lobbied for
evidence
GXO Logistics, Inc.
LDA RR 2026 fourth quarter · Transportation, Budget/appropriations, Defense, Government issues · Nov 2, 2026
Lobbied for
evidence
BRISTOL MYERS SQUIBB CO
LDA RR 2026 first quarter · Health issues, MED, Medicare/Medicaid · Aug 26, 2026
Lobbied for
evidence
Emergent BioSolutions Inc.
LDA Q2 2026 second quarter · Health issues · Aug 26, 2026
Lobbied for
evidence
AMGEN INC
LDA Q2 2026 second quarter · Medicare/Medicaid · Aug 26, 2026
Lobbied for
evidence
FUELCELL ENERGY INC
LDA Q2 2026 second quarter · Taxation · Aug 26, 2026
Lobbied for
evidence
NEUROCRINE BIOSCIENCES INC
LDA Q1 2026 first quarter · Budget/appropriations, Health issues, Medicare/Medicaid · Aug 26, 2026
Lobbied for
evidence
Perimeter Solutions, Inc.
LDA Q2 2026 second quarter · CHM · Aug 26, 2026
Lobbied for
evidence
ARDELYX, INC.
LDA 1TY 2026 first quarter · issues not listed · Aug 26, 2026
Lobbied for
evidence
TransUnion
LDA Q2 2026 second quarter · BNK, Consumer issues, Budget/appropriations · Aug 26, 2026
Lobbied for
evidence
NIKE, Inc.
LDA Q2 2026 second quarter · Copyright/patent, Science/technology, Trade, APP · Aug 26, 2026
Lobbied for
evidence
VERIZON COMMUNICATIONS INC
LDA Q1 2026 first quarter · Telecommunications, Copyright/patent · Aug 26, 2026
Lobbied for
evidence
Walmart Inc.
LDA Q2 2026 second quarter · Trade, Consumer issues, Taxation · Aug 26, 2026
Lobbied for
evidence
LAS VEGAS SANDS CORP
LDA Q1 2026 first quarter · GAM, Taxation, FOR, TOU · Aug 26, 2026
Lobbied for
evidence
Santander Holdings USA, Inc.
LDA Q1 2026 first quarter · Banking · Aug 26, 2026
Lobbied for
evidence
DELTA AIR LINES, INC.
LDA Q2 2026 second quarter · Taxation, Aviation · Aug 26, 2026
Lobbied for
evidence
Disc Medicine, Inc.
LDA Q1 2026 first quarter · Health issues, Medicare/Medicaid · Aug 26, 2026
Lobbied for
evidence
ALNYLAM PHARMACEUTICALS, INC.
LDA Q2 2026 second quarter · MED · Aug 26, 2026
Lobbied for
evidence
CAPITAL ONE FINANCIAL CORP
LDA Q2 2026 second quarter · Taxation, Telecommunications, Banking · Aug 26, 2026
Lobbied for
evidence
Fox Corp
LDA Q2 2026 second quarter · Taxation · Aug 26, 2026
Lobbied for
evidence
LOCKHEED MARTIN CORP
LDA Q1 2026 first quarter · DIS, Defense, Taxation · Aug 26, 2026
Lobbied for
evidence
Duke Energy CORP
LDA Q1 2026 first quarter · Taxation · Aug 26, 2026
Lobbied for
evidence
PNC FINANCIAL SERVICES GROUP, INC.
LDA Q2 2026 second quarter · Banking, Financial institutions · Aug 26, 2026
Lobbied for
evidence
GSK plc
LDA Q2 2026 second quarter · Health issues, Medicare/Medicaid · Aug 26, 2026
Lobbied for
evidence
MADRIGAL PHARMACEUTICALS, INC.
LDA RR 2026 first quarter · Health issues, MED, Medicare/Medicaid · Aug 26, 2026
Lobbied for
evidence
Verisk Analytics, Inc.
LDA Q2 2026 second quarter · Budget/appropriations, INS · Aug 26, 2026